Homocystinuria in a consanguineous indigenous family from rural Honduras: a ten-year follow up and literature review of familial cases
https://orcid.org/0009-0004-6750-0250
Eduardo Rene Schrunder
https://orcid.org/0009-0006-0230-2119
Linda Skewes Kennedy
https://orcid.org/0000-0001-8081-0844
Mary D. Chamberlin
César Ulises Alas Pineda
https://orcid.org/0000-0003-4183-9104
Abstract
Homocystinuria (HCU) is a rare autosomal recessive metabolic disorder, characterized by a mutation in the enzyme cystathionine beta-synthase and abnormally high levels of homocysteine in the blood. HCU that runs in a family is rare; prior to this report, there have been only 150 familial cases described in the literature. Here, we describe a familial cluster of HCU in four children in “Family V,” a consanguineous indigenous family from rural Honduras with a 10-year clinical follow up. We describe the diagnosis, presentation and progression of three patients who were diagnosed in 2015; critical findings include substantial vision loss in Patients 1 and 2, and a significant decline in language ability in Patient 3. We also describe the presentation of Patient 4, a grandchild who we diagnosed with probable HCU based on symptoms very similar to his siblings and highly suspicious for HCU. Additionally, we completed a narrative review of previously published familial HCU cases, using PubMed and Google Scholar, to highlight common phenotypic trends in familial HCU patients. In the reported familial cases, 57% had CNS complications, 48% had ocular complications, and 30% had cardiovascular complications.
##plugins.themes.bootstrap3.article.details##
Homocystinuria, Cystathionine beta-synthase deficiency, Consanguinity, Familial case series, Rare metabolic disease, Rural healthcare
2. Garland J, Prasad A, Vardy C, Prasad C. Homocystinuria: Challenges in diagnosis and management. Paediatr Child Health. 1999 Nov;4(8):557-62. doi: 10.1093/pch/4.8.557. PMID: 20213008; PMCID: PMC2830775.
3. Jain M, Shah M, Thakker KM, et al. Estimating prevalence of classical homocystinuria in the United States using Optum's de-identified market clarity data. Mol Genet Metab Rep. 2024 Jun 7;40:101101. doi: 10.1016/j.ymgmr.2024.101101. PMID: 38962401; PMCID: PMC11219957.
4. Buckley MMM, Aguilar LB, Lainez RC, et al. Neonatal screening program for five conditions in Honduras. J Community Genet. 2021 Jul;12(3):389-395. doi: 10.1007/s12687-021-00506-7. Epub 2021 Jan 18. PMID: 33462772; PMCID: PMC8241961.
5. Giugliani R, Castillo Taucher S, Hafez S, et al. Opportunities and challenges for newborn screening and early diagnosis of rare diseases in Latin America. Front Genet. 2022 Dec 8;13:1053559. doi: 10.3389/fgene.2022.1053559. PMID: 36568372; PMCID: PMC9773081.
6. Turner SA, Dinulos MBP, Vallee SE, et al. Discovery of a novel cystathionine-beta-synthase mutation and diagnosis of homocystinuria by whole exome sequencing in a family from rural Honduras. Case Rep Clin Pathol. 2015 Apr 17;2(3):p59. doi:10.5430/crcp.v2n3p59
7. Yap S, Boers GH, Wilcken B, et al. Vascular outcome in patients with homocystinuria due to cystathionine beta-synthase deficiency treated chronically: a multicenter observational study. Arterioscler Thromb Vasc Biol. 2001 Dec;21(12):2080-5. doi: 10.1161/hq1201.100225. PMID: 11742888.
8. Waheed N, Fayyaz Z, Imran A. Spectrum of clinical manifestation of methylmalonic acidemia and homocystinuria in a family of six siblings: novel combination of transcobalamin receptor defect (CD320) and cblC deficiency (MMACHC). Egypt J Med Hum Genet. 2021 Oct 1;22(1):75. doi:10.1186/s43042-021-00197-2
9. Kluijtmans LA, Wendel U, Stevens EM, et al. Identification of four novel mutations in severe methylenetetrahydrofolate reductase deficiency. Eur J Hum Genet. 1998 May-Jun;6(3):257-65. doi: 10.1038/sj.ejhg.5200182. PMID: 9781030.
10. Naeem B, Nasim J, Irfan M, Ayesha H. Clinical diversity in pediatric homocystinuria: A case series of siblings. Med Rep. 2023 Dec 1;2:100019. doi:10.1016/j.hmedic.2023.100019
11. Thomas RP, Holloell JG, Peters HJ, Coryell ME, Lester RH. Homocystinuria and ectopia lentis in Negro family. JAMA. 1966 Oct 31;198(5):560-2. PMID: 5953281.
12. Wong PW, Justice P, Hruby M, Weiss EB, Diamond E. Folic acid nonresponsive homocystinuria due to methylenetetrahydrofolate reductase deficiency. Pediatrics. 1977 May;59(5):749-56. PMID: 854378.
13. Herrera-Paz EF. Aislamientos genéticos y costumbres endogámicas en tres municipios rurales de Honduras [Genetic isolates and inbreeding customs in three rural municipalities from Honduras]. Rev Med Inst Mex Seguro Soc. 2016 Jul-Aug;54(4):504-13. Spanish. PMID: 27197108.
14. Lipson MH, Kraus J, Rosenberg LE. Affinity of cystathionine beta-synthase for pyridoxal 5'-phosphate in cultured cells. A mechanism for pyridoxine-responsive homocystinuria. J Clin Invest. 1980 Aug;66(2):188-93. doi: 10.1172/JCI109843. PMID: 7400312; PMCID: PMC371697.
15. Morris AA, Kožich V, Santra S, et al. Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency. J Inherit Metab Dis. 2017 Jan;40(1):49-74. doi: 10.1007/s10545-016-9979-0. PMID: 27778219; PMCID: PMC5203861.
16. Giugliani R, Castillo Taucher S, et al. Opportunities and challenges for newborn screening and early diagnosis of rare diseases in Latin America. Front Genet. 2022 Dec 8;13:1053559. doi: 10.3389/fgene.2022.1053559. PMID: 36568372; PMCID: PMC9773081.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Archive of Clinical Cases is protected by copyright and may be used in accordance with copyright and other applicable laws. Content available at www.clinicalcases.eu and our digital applications is intended for personal noncommercial use.
Authors who submit a manuscript for publication in Archive of Clinical Cases agree to the following terms: a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) only after the final version of the manuscript was accepted and published, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access). d. It is compulsory that before submission authors ensure that their work was not published in any other medical journals or pending acceptance for publication and that "Archives of Clinical Cases" is the only beneficiary at that moment if their work/case will be accepted by us.
Guidelines for linking to www.clinicalcases.eu a. The main purpose of the site linking to the Archive of Clinical Casess site should be educational. b. Links should be made to the Archive of Clinical Casess home page (www.clinicalcases.eu) or to the articles abstract. c. It is forbidden to use the Archive of Clinical Casess cover by outside organizations unless permission has been granted in advance, notifying our Secretary. d. Material owned by the Archive of Clinical Cases (including the name, logo, cover, and text) may not be used in any manner that may induce the idea or suggest that the Archive of Clinical Cases is in some way recommending a specific company, product or service. e. You must not use or allow others to access or use, all or any part of our Site or the contents and/or applications on it for commercial purposes without our permission. To seek permission to do anything prohibited by or not contained in these TERMS, or which requires our prior consent or agreement, you can contact us.